IMNP's 2017 Financial ResultsPlease take a look at IMNP's 2017 Financial Results at:
https://web.tmxmoney.com/article.php?newsid=8042502986999759&qm_symbol=IMNP:US ------The following is a quote from this report: "Elliot Maza, President and CEO of Immune, commented, "We made notable progress over the course of 2017. We worked diligently to focus our efforts and establish a clear path forward for bertilimumab and NanoCyclo by implementing our strategic corporate restructuring, prioritizing and segregating our research and development efforts, and strengthening our financial position. We have an excellent team in place to support our two exciting programs and advance the Company, and we are well positioned to have a breakthrough year in 2018..." "